News: biochemistry

VICC Named to Proteomic Cancer Research Consortium

Thursday, December 8th, 2011

A team of Vanderbilt-Ingram Cancer Center scientists, led by Daniel Liebler, Ph.D., professor of Biochemistry, Biomedical Informatics and Pharmacology, has been selected to participate in the Clinical Proteomic Tumor Analysis Consortium (CPTAC), a multi-center cancer research program created by the National Cancer Institute (NCI). Liebler will lead the Vanderbilt Proteome Characterization Center, one of five […]

Guengerich Lauded for Contributions

Friday, September 2nd, 2011

F. Peter (Fred) Guengerich, Ph.D., interim chair of the Department of Biochemistry, received the American Chemical Society Division of Chemical Toxicology Founders’ Award at the society’s annual meeting this week. The award recognizes Guengerich’s outstanding research accomplishments and his numerous contributions to the field of chemical toxicology. “This means a lot to me in that […]

Magnet to Enhance Cancer Drug Discovery

Friday, May 13th, 2011

Onlookers cheered early on the morning of Saturday, May 7, as a shattering champagne bottle christened the delivery of a $5 million, 7.5-ton magnet to Vanderbilt University. The magnet is the main part of an ultra-high field, 900 megahertz nuclear magnetic resonance (NMR) spectrometer that will help researchers solve the mysteries of cancer, Alzheimer’s disease […]

Cancer Gene’s Role in Outcomes Prediction

Friday, March 25th, 2011

A new study by Vanderbilt-Ingram Cancer Center investigators reveals that a gene signature may be useful in predicting outcomes for patients with rhabdomyosarcoma, a form of cancer most commonly diagnosed in children. The study, carried out by first author Jennifer Rosenbluth, Ph.D.; Jennifer Pietenpol, Ph.D., professor of Biochemistry, Cancer Biology and Otolaryngology and director of […]